Subscribe Now Subscribe Today
Science Alert
 
Blue
   
Curve Top
International Journal of Cancer Research
  Year: 2018 | Volume: 14 | Issue: 1 | Page No.: 1-12
DOI: 10.3923/ijcr.2018.1.12
 
Facebook Twitter Digg Reddit Linkedin StumbleUpon E-mail

Analysis of Sensitivity and Cell Death Pathways Mediated by Anti-cancer Drugs Using Three-dimensional Culture System

Takeshi Kinoshita, Hajime Higuchi , Ayano- Kabashima-Niibe, Gen Sakai, Yasuo Hamamoto, Hiromasa Takaishi and Takanori Kanai

Abstract:
Objective: The aim of this study was to evaluate the differences of cytotoxicity mediated by anti-cancer drugs between 2D and 3D culture conditions. Methodology: The colon cancer cell line HCT116 was cultured in 2D and 3D conditions. Anti-proliferation effects and cell death pathways of cytotoxic agents, i.e., SN-38 and multi-kinase inhibitors i.e., sorafenib were examined. Data was analyzed by Student’s t-test. Results: Although SN-38 induced significant apoptosis associated with caspase-3/7 activation in 2D condition, apoptosis and anti-proliferation effects of SN-38 dramatically diminished in 3D condition. In contrast, anti-proliferation effects mediated by sorafenib unchanged. Interestingly, sorafenib induced significant apoptosis in the cells locating in the center of the 3D spheroids, whereas it did not induce caspase activation in 2D condition. In addition, 2D culture with low glucose concentration, a model mimicking central condition of the spheroids, revealed the significant cell death with caspase activation by sorafenib. Conclusion: 3D culture system provide new findings regarding cytotoxicity of compounds which are not identified by the 2D culture.
PDF Fulltext XML References Citation Report Citation
How to cite this article:

Takeshi Kinoshita, Hajime Higuchi, Ayano- Kabashima-Niibe, Gen Sakai, Yasuo Hamamoto, Hiromasa Takaishi and Takanori Kanai, 2018. Analysis of Sensitivity and Cell Death Pathways Mediated by Anti-cancer Drugs Using Three-dimensional Culture System. International Journal of Cancer Research, 14: 1-12.

DOI: 10.3923/ijcr.2018.1.12

URL: https://scialert.net/abstract/?doi=ijcr.2018.1.12

COMMENT ON THIS PAPER
 
 
 

 

 
 
 
 
 
 
 
 
 

 
 
 
 
 
 
 
 

Curve Bottom